Related Articles
Metronomic chemotherapy for metastatic breast cancer to prolong time to treatment failure to 12 months or more
Cancer cachexia as a determinant of efficacy of first‑line pembrolizumab in patients with advanced non‑small cell lung cancer
Value of TTF‑1 expression in non‑squamous non‑small‑cell lung cancer for assessing docetaxel monotherapy after chemotherapy failure
Radiofrequency ablation vs. hepatectomy for liver metastases from gastrointestinal stromal tumors
Feasibility and safety of platinum‑doublet therapy in patients with small‑cell lung cancer in the third‑line setting: <br />A multi‑institutional retrospective study